1819OTumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer. (23rd October 2018) - Leboulleux, S; Lee, E K; Bastholt, L; Tahara, M; Wirth, L J; Sherman, S I; Robinson, B G; Teng, A; Joshi, P; Misir, S; Dutcus, C E; Tuttle, R M; et al.